Gil Isabel, Costa Paulo, Parola Vítor, Cardoso Daniela, Almeida Maria, Apóstolo João
Escola Superior de Enfermagem de Coimbra, Coimbra, Portugal.
Unidade de Investigação em Ciências da Saúde, Enfermagem, Coimbra, Portugal.
Rev Esc Enferm USP. 2019 Mar 28;53:e03458. doi: 10.1590/S1980-220X2018007403458.
To identify the best available evidence on the efficacy of Reminiscence Therapy in cognition, depressive symptoms and quality of life in elderly individuals with cognitive impairment.
The methodology proposed by the Joanna Briggs Institute was used. Studies focused on group Reminiscence Therapy aimed at institutionalized elderly people with cognitive impairment aged 65 or over were considered. The critical analysis, extraction and synthesis of results was performed by two independent researchers.
Four randomized clinical trials and two quasi-experimental studies (n=296) were included. Given the heterogeneous characteristics of studies found, it was impossible to perform a meta-analysis. Of the six studies included, two presented statistically significant results for efficacy in cognition, and three for efficacy in reducing depressive symptoms. In none of the studies was evaluated the elderly's quality of life.
Reminiscence Therapy has potential efficacy for maintaining cognition and decrease of depressive symptomatology in the target population.
确定关于回忆疗法对认知功能受损老年人的认知、抑郁症状及生活质量疗效的最佳现有证据。
采用乔安娜·布里格斯研究所提出的方法。纳入针对65岁及以上认知功能受损的机构养老老年人的团体回忆疗法研究。由两名独立研究人员进行结果的批判性分析、提取和综合。
纳入四项随机临床试验和两项准实验研究（n = 296）。鉴于所发现研究的异质性特征，无法进行荟萃分析。在纳入的六项研究中，两项在认知疗效方面呈现出具有统计学意义的结果，三项在减轻抑郁症状疗效方面呈现出具有统计学意义的结果。没有一项研究评估老年人的生活质量。
回忆疗法对目标人群维持认知功能和减轻抑郁症状具有潜在疗效。
